Suppr超能文献

柳氮磺胺吡啶与金制剂及安慰剂治疗类风湿关节炎的比较。

Comparisons of sulfasalazine to gold and placebo in the treatment of rheumatoid arthritis.

作者信息

Williams H J

机构信息

Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City 84132.

出版信息

J Rheumatol Suppl. 1988 Sep;16:9-13.

PMID:2903928
Abstract

Studies comparing sulfasalazine to gold or placebo are few in number. Two controlled trials have been conducted comparing sulfasalazine and placebo, and 2 uncontrolled trials have compared sulfasalazine and gold sodium thiomalate. A controlled trial conducted by the Cooperative Systematic Studies of Rheumatic Diseases compared enteric coated sulfasalazine, gold, and placebo. These studies suggest that sulfasalazine is superior to placebo but is associated with significant side effects, particularly gastrointestinal. These studies also suggest that sulfasalazine is similar in efficacy to gold, but with lesser and milder toxicity. Additional comparison studies are indicated.

摘要

将柳氮磺胺吡啶与金制剂或安慰剂进行比较的研究数量较少。已进行了两项比较柳氮磺胺吡啶与安慰剂的对照试验,还有两项非对照试验比较了柳氮磺胺吡啶与硫代苹果酸金钠。风湿性疾病协作系统研究进行的一项对照试验比较了肠溶包衣柳氮磺胺吡啶、金制剂和安慰剂。这些研究表明,柳氮磺胺吡啶优于安慰剂,但会伴有显著的副作用,尤其是胃肠道副作用。这些研究还表明,柳氮磺胺吡啶在疗效上与金制剂相似,但毒性更小、更轻。需要进行更多的比较研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验